The Global Tech Platform Aiming to Revamp Cancer Care

Driver, developed by a Harvard-trained oncologist, aims to connect cancer patients with tailored treatments globally. The platform addresses market failures in accessing treatments and clinical trials, exacerbated by a shortage of oncologists. Driver acts as a technological intermediary between patients and doctors, enhancing treatment access. The company positions itself as a tech firm, not a healthcare entity, focusing on patient-centric solutions and avoiding reliance on big pharma for funding.

Describe the market failure mentioned in relation to cancer treatment access.

What is the primary function of the Driver platform?

What percentage of Americans currently have access to clinical trials?

What are the two major issues affecting oncologist availability?

What is the significance of the statistic regarding oncologists per million people in the US compared to China?

How does Driver aim to bridge the gap in cancer treatment access?

Explain the relationship Driver seeks to establish between patients and doctors.